OKAY. DOCTOR RAJ Mass Gen's Dr. Ali Raja explains why some were sent to the emergency room after using semaglutide injections. Raja says some of the symptoms people experienced won't require an ER ...

I had been practicing — this had been going on for two years. Until two years ago, I used to play by taking injections. We didn't know what was going on in India as we didn't know what the issue ...

While appearing on Wednesday’s episode of the “Table Manners” podcast with singer Jessie Ware and her mother, Lennie Ware, the “Only Murders in the Building” star and music producer revealed how their ...

While she is on the road to recovery, the 40-year-old shared that persistent skin rashes and intense itching have made her recovery uncomfortable. Taking to her social media, Tripathi posted ...

However, they cautioned that there were no health-related quality of life, respiratory symptoms, or lung function benefits as previously seen with dupilumab (Dupixent) in a similar COPD population ...

Dupilumab shows significant efficacy in reducing itch and hives in CSU patients unresponsive to antihistamines. The CUPID A and CUPID C trials reported a two-thirds reduction in itch and urticaria ...

The improper input validation flaw allows attackers with admin access to modify firmware and run arbitrary code on affected SAN environments. A high severity flaw affecting Broadcom’s Brocade ...

Those include injection site reactions, common cold symptoms, and upper respiratory tract infections. There’s a slightly higher risk of developing lung infections and heart-related health events on ...

After May 22, compounding pharmacies can no longer make and sell semaglutide injections. They were initially allowed to because the FDA declared a shortage, but that period has ended. At Melrose ...

Wrexham's promotion to the Championship has not only thrilled fans but also promises a substantial monetary gain for celebrity duo Rob McElhenney and Ryan Reynolds. The owners are poised to ...

The trial enrolled 118 patients with colorectal cancer across 23 medical centers who had developed moderate to severe acneiform rashes while taking an EGFR inhibitor. Patients were randomly ...

Patients had colorectal cancer and developed moderate to severe rashes while taking cetuximab or panitumumab, two common anti-EGFR treatments. The participants were randomly divided into three groups.